Pliant Therapeutics (PLRX) Cash from Financing Activities (2019 - 2026)
Pliant Therapeutics (PLRX) posted Cash from Financing Activities of $74,000 for Q1 2026, down 85.1% from $498,000 a year earlier.
Powered by 
Analysis
Pliant Therapeutics (PLRX) Cash from Financing Activities (2019 - 2026) Analysis & Trends
For FY2025, Pliant Therapeutics' Cash from Financing Activities came in at -$31.7 million.
- In prior years, Pliant Therapeutics' Cash from Financing Activities was $23.12 million in FY2024 (-91.6%), $274.41 million in FY2023 (+21.0%), $226.85 million in FY2022 and $2.53 million in FY2021 (-98.8%).
- Quarterly Cash from Financing Activities has run from a low of -$32.27 million in Q4 2025 to a high of $273.33 million in Q1 2023 over five years.
- On a year-over-year basis, Cash from Financing Activities increased in 1 of the last six quarters, with an average decline of 3.4%.
- The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q2 2024, with growth of 324.8%; the weakest was Q2 2021, with a decline of 99.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Pliant Therapeutics | 66.87 Mn | 66.87 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 74,000.00 |
| Dec 31, 2025 | -32.27 Mn |
| Sep 30, 2025 | 72,000.00 |
| Mar 31, 2025 | 498,000.00 |
| Dec 31, 2024 | 102,000.00 |
| Sep 30, 2024 | 543,000.00 |
| Jun 30, 2024 | 684,000.00 |
| Mar 31, 2024 | 21.79 Mn |
| Dec 31, 2023 | 219,000.00 |
| Sep 30, 2023 | 699,000.00 |
| Jun 30, 2023 | 161,000.00 |
| Mar 31, 2023 | 273.33 Mn |
| Dec 31, 2022 | 284,000.00 |
| Sep 30, 2022 | 216.30 Mn |
| Jun 30, 2022 | 10.43 Mn |
| Mar 31, 2022 | -153,000.00 |
| Dec 31, 2021 | 516,000.00 |
| Sep 30, 2021 | 449,000.00 |
| Jun 30, 2021 | 192,000.00 |
| Mar 31, 2021 | 1.37 Mn |
API Access
Pliant Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "PLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();